US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AI Healthcare

727.88

-19.2295-2.57%

Number of Gainers:- -

Number of Losers:4

Number of Flat:- -

PE:- -

High:743.30

Open:742.99

Low:722.00

Close:747.11

Volume:23.98M

Turnover:449.94M

Market Cap:22.82B

Float Cap:16.53B

Loading ...

Tempus AI Unveils Eight New GI Cancer Studies at 2026 ASCO Symposium

Tempus AI COO Ryan Fukushima Reports Disposal of Common Shares

Recursion Pharmaceuticals Director Christopher Gibson Reports Sale of Common Shares

Tempus AI Director Jennifer Doudna Reports Sale of Common Shares

Tempus AI Inc. to Present at J.P. Morgan Healthcare Conference

Cathie Wood Loads Up On Tempus AI And This George Soros-Backed Company's Stock, Dumps Roku And Shopify Shares

Benzinga_recent_news

Recursion Pharmaceuticals (RXRX): Assessing Valuation After New Activist Investor Filings With the SEC

Simply Wall St.

Getty Images, Torm, and More Stocks See Action From Activist Investors -- Barrons.com

Cathie Wood's Biotech Trend: Twist, Beam, CRISPR Latest Stock Picks

Benzinga_recent_news

AI Integration In MedTech Devices And Diagnostics: Regulation And Investment Opportunities

Benzinga_recent_news

Recursion CFO Ben R. Taylor Reports Sale of Common Shares

Chief R&D Commercial Officer Najat Khan Sells Recursion Pharmaceuticals Common Shares

3 Small AI Plays to Buy for 2026

Benzinga_recent_news

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4611/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4611","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4611\",,,,,undefined,":{"symbol":"BK4611","market":"US","secType":"PLATE","nameCN":"AI Healthcare","latestPrice":727.87854,"timestamp":1767905999999,"preClose":747.10803,"halted":0,"volume":23980272,"delay":0,"changeRate":-0.025739,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-19.229492,"latestTime":"01-08 16:00:00 EST","open":742.99176,"high":743.3002,"low":722.0042,"amount":449944874.88943,"amplitude":0.028505,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1767969000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.202502,"peRate":-12.666128,"turnoverRate":0.034397,"increases":0,"decrements":4,"flats":0,"marketCap":22821208832,"floatMarketCap":16526001280},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4611\",,,,,undefined,":{"symbol":"BK4611","high":743.3002,"amplitude":0.028505,"preClose":747.10803,"low":722.0042,"pbRate":"5.202502","latestPrice":727.87854,"volume":23980272,"delay":0,"open":742.99176,"prevYearClose":658.3995,"prevWeekClose":677.6836,"prevMonthClose":658.3995,"prevQuarterClose":658.3995,"fiveDayClose":658.3995,"twentyDayClose":757.9016,"sixtyDayClose":894.5567,"secType":"PLATE","market":"US","turnoverRate":0.034397,"peRate":-12.666128,"marketCap":22821208832,"floatMarketCap":16526001280,"timestamp":1767905999999,"nameCN":"AI Healthcare"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4611\",,,,undefined,":{"bkCode":"BK4611","up":0,"down":4,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4611\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2601362996","title":"Tempus AI Unveils Eight New GI Cancer Studies at 2026 ASCO Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2601362996","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601362996?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:30","pubTimestamp":1767879059,"startTime":"0","endTime":"0","summary":"Tempus AI Inc. announced that eight abstracts have been accepted for presentation at the 2026 ASCO Gastrointestinal Cancers Symposium, scheduled for January 8-10 in San Francisco, California. The presentations will highlight Tempus’ latest scientific and clinical research findings in gastrointestinal cancers, using their multimodal database to uncover insights in oncology. Notable studies include genomic profiling of epithelial neoplasms of the appendix and analysis of transcriptomic signatures predicting improved survival with platinum therapy in BRCA/PALB2 wild-type metastatic pancreatic cancer. The results of these studies will be presented at the upcoming symposium.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempus AI Inc. publ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDL272t0t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861558580.USD","LU1861559042.SGD","BK4121","BK4611","TEM","BK4613"],"gpt_icon":1},{"id":"2601382718","title":"Tempus AI COO Ryan Fukushima Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2601382718","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601382718?lang=en_us&edition=fundamental","pubTime":"2026-01-08 07:25","pubTimestamp":1767828348,"startTime":"0","endTime":"0","summary":"Ryan Fukushima, Chief Operating Officer of Tempus AI Inc., reported a disposal of common shares of Tempus AI Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempus AI Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 07, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nNDL8Pdb34:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Tempus AI COO Ryan Fukushima Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861558580.USD","TEM","BK4121","BK4611","BK4613","LU1861559042.SGD"],"gpt_icon":1},{"id":"2601705381","title":"Recursion Pharmaceuticals Director Christopher Gibson Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2601705381","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601705381?lang=en_us&edition=fundamental","pubTime":"2026-01-08 06:04","pubTimestamp":1767823495,"startTime":"0","endTime":"0","summary":"Christopher Gibson, Director of Recursion Pharmaceuticals Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Recursion Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 07, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nNDL1bGhlZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Recursion Pharmaceuticals Director Christopher Gibson Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","RXRX","BK4611","BK4609","BK4548"],"gpt_icon":1},{"id":"2601843361","title":"Tempus AI Director Jennifer Doudna Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2601843361","media":"Reuters","labels":["insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601843361?lang=en_us&edition=fundamental","pubTime":"2026-01-07 05:16","pubTimestamp":1767734160,"startTime":"0","endTime":"0","summary":"Jennifer A. Doudna, Director of Tempus AI Inc., has reported a disposal of Class A Common Shares of Tempus AI Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempus AI Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 06, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nNDL4bvRtz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Tempus AI Director Jennifer Doudna Reports Sale of Common Shares","news_tag":"insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4613","BK4611","BK4121","TEM","LU1861559042.SGD","LU1861558580.USD"],"gpt_icon":1},{"id":"2601890639","title":"Tempus AI Inc. to Present at J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2601890639","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601890639?lang=en_us&edition=fundamental","pubTime":"2026-01-06 21:31","pubTimestamp":1767706273,"startTime":"0","endTime":"0","summary":"Tempus AI Inc. will participate in the 44th Annual J.P. Morgan Healthcare Conference, scheduled to take place from January 12-15, 2026, in San Francisco, California. Tempus Founder and CEO Eric Lefkofsky is set to deliver a presentation and take part in a live Q&A session on January 12, 2026, from 1:30 to 2:10 PM PST. The event will be available via live webcast.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempus AI Inc. published the original content used to generate this news brief via Business Wire  on January 06, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nNDL6rc9Zj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4613","LU1861559042.SGD","BK4611","BK4121","LU1861558580.USD","TEM"],"gpt_icon":1},{"id":"2601823850","title":"Cathie Wood Loads Up On Tempus AI And This George Soros-Backed Company's Stock, Dumps Roku And Shopify Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2601823850","media":"Benzinga_recent_news","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601823850?lang=en_us&edition=fundamental","pubTime":"2026-01-06 11:16","pubTimestamp":1767669360,"startTime":"0","endTime":"0","summary":"On Monday, Jan. 5, 2026, Cathie Wood-led ark purchased Tempus AI and Kodiak AI shares while selling Roku and Shopify stock","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/05/Ark-Invest-Cathie-Wood_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/05/Ark-Invest-Cathie-Wood_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/etfs/broad-u-s-equity-etfs/26/01/49713669/cathie-wood-loads-up-on-tempus-ai-and-this-george-soros-backed-companys-stock-dumps-roku-and-shopify-shares","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/etfs/broad-u-s-equity-etfs/26/01/49713669/cathie-wood-loads-up-on-tempus-ai-and-this-george-soros-backed-companys-stock-dumps-roku-and-shopify-shares","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU1691799644.USD","KDK","BK4121","BK4023","LU1804176565.USD","BK4611","BK4585","BK4587","BK4613","LU1712237335.SGD","LU1720051017.SGD","LU1720051108.HKD","BK4507","BK4524","BK4544","BK4588","LU0390134368.USD","TEM","LU1623119135.USD","BK4532","LU1169590202.USD","LU0823421333.USD","LU2357305700.SGD","BK4548","BK4108","BK4528","LU1861558580.USD","LU2063271972.USD","BK4543","BK4141","LU0081259029.USD","LU1169589451.USD","LU0823421416.USD","LU1861559042.SGD","BK4551","SHOP","LU1548497426.USD","BK4566","ROKU","LU2265009873.SGD","BK4116"],"gpt_icon":1},{"id":"2601261071","title":"Recursion Pharmaceuticals (RXRX): Assessing Valuation After New Activist Investor Filings With the SEC","url":"https://stock-news.laohu8.com/highlight/detail?id=2601261071","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601261071?lang=en_us&edition=fundamental","pubTime":"2026-01-05 09:24","pubTimestamp":1767576249,"startTime":"0","endTime":"0","summary":"Reports that activist investors have filed with the SEC regarding Recursion Pharmaceuticals (RXRX) are drawing fresh attention to the stock, as shareholders weigh what potential strategic or management changes might follow.\nSee our latest analysis for Recursion Pharmaceuticals.\nThe activist filings land at a tricky moment for Recursion, with a 30 day share price return of minus 10.83 percent and a 12 month total shareholder return of minus 46.15 percent. This suggests momentum has been fading...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rxrx/recursion-pharmaceuticals/news/recursion-pharmaceuticals-rxrx-assessing-valuation-after-new","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rxrx/recursion-pharmaceuticals/news/recursion-pharmaceuticals-rxrx-assessing-valuation-after-new","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4551","BK4543","BK4587","RXRX","BK4023","BK4611","BK4548","BK4585","AI","BK4609","BK4588","BK4139","BK4539","BK4528"],"gpt_icon":1},{"id":"2600098839","title":"Getty Images, Torm, and More Stocks See Action From Activist Investors -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2600098839","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600098839?lang=en_us&edition=fundamental","pubTime":"2026-01-03 04:22","pubTimestamp":1767385320,"startTime":"0","endTime":"0","summary":"These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from Dec. 25 through Dec. 31, 2025. Source: VerityData. Getty Images Holdings  Neuberger Berman reduced its stake in the digital image marketplace operator to 55,213,295 shares. Neuberger Berman did so through the open market sale of 3,470,917 Getty Images shares on Oct. 31 at per share prices ranging from $1.97 to $2.75, as well as a pro rata in-kind distribution of 15,428,050 shares to limited partners on Dec. 17. Following the latest activity, Neuberger continues to ow","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4231","BK4548","BK4611","BK4077","CAMP","LU0997586861.USD","BK4211","BK4585","BK4139","BK4609","TRMD","BK4588","GETY","BK4144","BK4020","BK4080","RXRX","VOR"],"gpt_icon":0},{"id":"2600040807","title":"Cathie Wood's Biotech Trend: Twist, Beam, CRISPR Latest Stock Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2600040807","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600040807?lang=en_us&edition=fundamental","pubTime":"2026-01-01 06:06","pubTimestamp":1767218760,"startTime":"0","endTime":"0","summary":"The massive rotation currently unfolding within ARK Invest suggests that Cathie Wood thinks 2026 will be the year of the genomic revolution.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/31/Cathie-Wood-Doubles-Down-On-Bitcoin-ETF-.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/31/Cathie-Wood-Doubles-Down-On-Bitcoin-ETF-.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/etfs/specialty-etfs/25/12/49657695/cathie-woods-biotech-trend-twist-beam-crispr-latest-stock-picks","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/etfs/specialty-etfs/25/12/49657695/cathie-woods-biotech-trend-twist-beam-crispr-latest-stock-picks","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["TQQQ","SQQQ","LU0820562030.AUD","IE00B19Z9505.USD","LU0823411888.USD","LU2471134523.USD","LU1066051498.USD","LU2417539215.USD","LU2236285917.USD","TWST","LU0077335932.USD","LU1839511570.USD","LU0820561818.USD","LU0323591593.USD","PSQ","LU1861559042.SGD","LU0056508442.USD","QLD","LU0719512351.SGD","LU2750360997.AUD","LU0053666078.USD","LU1066051225.USD","BK4505","BK4543","LU1861558580.USD","BEAM","LU2403377893.USD","LU1232071149.USD","LU1551013342.USD","LU1366192091.USD","LU2602419157.SGD","BK4598","BK4516","SG9999015986.USD","LU0345770308.USD","LU0672654240.SGD","LU0198837287.USD","LU0708995401.HKD","LU2471134879.HKD","PACB","LU2471134952.CNY","LU2250418816.HKD","BK4581","LU2249611893.SGD","NTLA","LU2456880835.USD","BK4533","LU2213496289.HKD","IE00BSNM7G36.USD","LU1861215975.USD","LU2750360641.GBP","BK4139","BK4099","LU1429558221.USD","LU2896262040.SGD","LU1066051811.HKD","BK4611","LU0689472784.USD","LU0234572021.USD","LU0234570918.USD","BK4551","LU1066053197.SGD","NVIW.SI","USJW.SI","BK4548","LU1861220033.SGD","TSYW.SI","LU1720051108.HKD","IE00B1BXHZ80.USD","IE00BK4W5L77.USD","LU0082616367.USD","LU1267930730.SGD","LU0964807845.USD","LU0345769128.USD","BK4592","IE00B19Z8W00.USD","BK4121","BK4556","LU0210536198.USD","LU1435385759.SGD","LU2420271590.USD","CRSP","LU0320765059.SGD","BK4187","LU2756315318.SGD","BK4588","IE00BJLML261.HKD","LU0820561909.HKD","SG9999015978.USD","LU2462157665.USD","LU2326559502.SGD","BK4550","BK4527","LU0348723411.USD","ARKK","BK4544","MNQmain","IE00BK4W5M84.HKD","BK4511","BK4555","IE00BWXC8680.SGD","LU0345769631.USD","LU1720051017.SGD","BK4564","SG9999015945.SGD","LU2108987350.USD","IE0034235303.USD","BK4604","LU1914381329.SGD","LU0316494557.USD","LU2023250330.USD","LU2357305700.SGD","LU2360106780.USD","BK4585","LU1551013425.SGD","BK4574","LU2087621335.USD","BK4534","LU2290526834.HKD","LU2360107168.USD","LU2756315664.SGD","USAW.SI","IE00B19Z8X17.USD","LU1145028129.USD","LU1629891620.HKD","LU0943347566.SGD","LU1548497426.USD","QID",".IXIC","LU1674673691.USD","LU1852331112.SGD","LU0109391861.USD","LU1778281490.HKD","NQmain","LU2063271972.USD","LU1674673428.USD","BK4535","BK4612","LU0345770993.USD","IE00B1XK9C88.USD","LU0823414478.USD","LU0097036916.USD","SG9999015952.SGD","LU0466842654.USD","LU2471134796.USD"],"gpt_icon":1},{"id":"2600708045","title":"AI Integration In MedTech Devices And Diagnostics: Regulation And Investment Opportunities","url":"https://stock-news.laohu8.com/highlight/detail?id=2600708045","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600708045?lang=en_us&edition=fundamental","pubTime":"2026-01-01 00:13","pubTimestamp":1767197580,"startTime":"0","endTime":"0","summary":"Medical technology is experiencing a paradigm shift as artificial intelligence moves from experimental labs into operating rooms and diagnostic centers worldwide. What once sounded like science fiction, such as robots assisting in delicate surgeries or algorithms spotting cancerous tumors invisible to the human eye, has become clinical reality. For investors tracking this evolution, understanding which companies are genuinely leading versus merely marketing buzzwords has never been more critical.By mid-2025, the FDA had cleared over 1,250 AI-powered medical devices for the US market. Three companies have positioned themselves at the forefront of this transformation.GE HealthCare Technologies Inc.  leads with 100 FDA-approved AI devices, concentrating heavily on imaging and diagnostics. Their CleaRecon DL technology sharpens cone-beam CT images using machine learning, while the Invenia Automated Breast Ultrasound Premium helps doctors screen patients with dense breast tissue more effici","market":"hk","thumbnail":"/next-assets/images/benzinga-post-card-placeholder.svg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["/next-assets/images/benzinga-post-card-placeholder.svg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/Opinion/25/12/49650518/ai-integration-in-medtech-devices-and-diagnostics-regulation-and-investment-opportunities","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/Opinion/25/12/49650518/ai-integration-in-medtech-devices-and-diagnostics-regulation-and-investment-opportunities","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["IE00B19Z8X17.USD","LU2089984988.USD","LU0976567544.SGD","LU0211331839.USD","LU2491049909.HKD","LU1923622614.USD","LU2271345857.HKD","LU2125909247.SGD","LU0354030511.USD","BK4613","MDT","LU1116320737.USD","LU1791710400.SGD","IE000M9KFDE8.USD","LU0265550946.USD","IE00B19Z9505.USD","BK4585","BK4533","BK4581","LU2404859667.USD","GB00B4LPDJ14.GBP","LU2089284900.SGD","LU1868836757.USD","LU0251132253.USD","IE00B3PB1722.GBP","LU2362540622.SGD","IE00BVYPNV92.GBP","BK4534","LU0690374615.EUR","BK4528","LU0096364046.USD","BK4566","LU2023251221.USD","IE00B19Z8W00.USD","LU0353189763.USD","LU2506951875.HKD","IE00BYQQ9H92.USD","LU1923623000.USD","LU0265550359.USD","IE00BFXG1179.USD","IE00BQXX3C00.GBP","LU0070302665.USD","LU1244550494.USD","IE00BDGV0183.EUR","BK4082","IE00BQXX3D17.EUR","LU0187121727.USD","BK4543","LU2242649171.HKD","LU1951198990.SGD","IE00BGHQF631.EUR","LU1989764748.USD","LU1861559042.SGD","ISRG","LU1989772840.SGD","IE00B3T34201.USD","LU2063271972.USD","SG9999013999.USD","LU0266013472.USD","BK4121","LU0211326839.USD","BK4023","LU2023250843.SGD","IE00B42XCP33.USD","BK4611","LU1720051017.SGD","LU2506951958.HKD","LU1291159041.SGD","BK4587","LU1989764664.SGD","LU0122379950.USD","SYK","LU1061106388.HKD","LU0882574055.USD","IE00BQXX3F31.USD","LU2265009873.SGD","LU1983299246.USD","LU0823416689.USD","LU0354030438.USD","LU0077335932.USD","LU0314106906.USD","BK4548","LU0950375773.USD","LU1720051108.HKD","LU1868836914.USD","LU0072461881.USD","LU0345769631.USD","IE00BFXG0V08.USD","LU0225283273.USD","LU2404859741.USD","BK4504","LU2506952170.USD","LU1153585028.USD","LU0353189680.USD","BSX","LU0289739699.SGD","LU2112291526.USD","BK4551","LU2244417387.USD","LU0496365809.HKD","LU2125909593.SGD","LU0158827781.USD","LU1974910355.USD","SG9999001176.USD","LU2362541273.HKD","LU0238689110.USD","LU0048584097.USD","IE00BJJMRZ35.SGD","LU0432979614.USD","LU1804176565.USD","LU0208291251.USD","GB00B4QBRK32.GBP","LU1951200564.SGD","LU1861558580.USD","IE00B5TLWC47.USD","IE00BFTCPJ56.SGD","LU1868837300.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU2324357040.USD","LU0061475181.USD","LU1868836591.USD","LU0211326755.USD","LU0690374961.EUR","LU1244550577.SGD","IE0002141913.USD","LU0079474960.USD","LU1244550221.USD","LU0320765489.SGD","LU1023059063.AUD","LU2468319806.SGD","LU1548497426.USD","LU2491050154.USD","LU0058720904.USD","LU2028103732.USD","LU0158827948.USD","LU1571399168.USD","GEHC","LU2362541513.USD","LU2491050071.SGD","IE0009355771.USD","IE00B4R5TH58.HKD","LU0823434740.USD","LU0097036916.USD","SGXZ57979304.SGD","LU1917777945.USD","BK4588","SG9999001176.SGD","LU0823434583.USD","LU2106854487.HKD","LU2089283258.USD","LU2506952097.USD","LU0267386448.USD","LU1116320901.HKD","LU1506573853.SGD","LU0390134368.USD","LU2087625088.SGD","LU1989771016.USD","LU0114720955.EUR","LU0162691827.USD","LU1989772923.USD","LU2023250504.SGD","LU1718418525.SGD","LU2433249047.HKD","IE00BVYPNW00.USD","LU0345769128.USD","LU1366192091.USD","LU0823417737.USD","LU0528227936.USD","LU1868837136.USD","LU1057294990.SGD","LU0011850046.USD","LU1791710582.SGD","LU2357305700.SGD","LU2111349929.HKD","LU0823417653.USD"],"gpt_icon":1},{"id":"2595140746","title":"Recursion CFO Ben R. Taylor Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2595140746","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595140746?lang=en_us&edition=fundamental","pubTime":"2025-12-31 08:35","pubTimestamp":1767141344,"startTime":"0","endTime":"0","summary":"Ben R. Taylor, Chief Financial Officer of Recursion Pharmaceuticals Inc., has reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Recursion Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 30, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251231:nNDL36v3wX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Recursion CFO Ben R. Taylor Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4611","BK4139","BK4548","BK4609","BK4539","RXRX"],"gpt_icon":1},{"id":"2595075565","title":"Chief R&D Commercial Officer Najat Khan Sells Recursion Pharmaceuticals Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2595075565","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595075565?lang=en_us&edition=fundamental","pubTime":"2025-12-30 06:25","pubTimestamp":1767047128,"startTime":"0","endTime":"0","summary":"Najat Khan, Chief R&D Commercial Officer and Director of Recursion Pharmaceuticals Inc., reported a disposal of Class A common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Recursion Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 29, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nNDLbjrRBp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Chief R&D Commercial Officer Najat Khan Sells Recursion Pharmaceuticals Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","RXRX","BK4609","BK4139","BK4611","BK4539"],"gpt_icon":1},{"id":"2594290785","title":"3 Small AI Plays to Buy for 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2594290785","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594290785?lang=en_us&edition=fundamental","pubTime":"2025-12-27 02:28","pubTimestamp":1766773680,"startTime":"0","endTime":"0","summary":"Wall Street ends 2026 positively with tech stocks dominating, but concerns over valuations drive interest in smaller AI stocks for 2026.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/26/AI-Race-Narrowing.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/26/AI-Race-Narrowing.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/trading-ideas/small-cap-analysis/25/12/49597501/3-small-ai-plays-to-buy-for-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/small-cap-analysis/25/12/49597501/3-small-ai-plays-to-buy-for-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4548","BK4611","LU1803068979.SGD","LU2054465674.USD","BK4106","BK4585","LU2023250504.SGD","IE0008368304.USD","LU0077335932.USD","LU2087625088.SGD","SG9999001424.SGD","LU0225283273.USD","LU0557290698.USD","LU2108987350.USD","BK4528","BK4123","BK4543","IE00BMPRXR70.SGD","IE00BN0W2W23.USD","LU2458330169.SGD","BK4539","LU0353189680.USD","LU2458330243.SGD","BK4554","BK4020","BK4587","BK4023","LU0889565833.HKD","LU0106261372.USD","LU2211815571.USD","ANET","INOD","LU0353189763.USD","LU1974910355.USD","IE00BN0W2T93.GBP","LU0348723411.USD","BK4139","LU0006306889.USD","BK4609","IE00BMPRXN33.USD","IE00BN0W2V16.EUR","RXRX","BK4588","LU2106854487.HKD","BK4551","LU1917777945.USD","LU0109392836.USD","LU2355687059.USD","IE00BMPRXQ63.HKD","LU2286300806.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":13,"code":"91000000","status":"200"}]}}